TRF-bio is a contract research organization (CRO) and a subsidiary of Celluris, dedicated to advancing innovative cell therapies for patients with unmet medical needs. Celluris is pioneering the development of CAR-T therapies for solid tumors, with a focus on translating breakthrough science into transformative treatments. The company has an active Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) and is currently advancing its program through late-stage preclinical development and clinical readiness activities. Located in Jerusalem, directly across from the Yitzhak Navon Train Station, TRF-bio provides a collaborative environment that supports the advancement of next-generation cell therapies.
| Employees | 2 (0 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular TRF-Bio employee's phone or email?
TRF-Bio Questions
